$GERN News Charting the latest market whipsaw 10:59 a.m.

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2013 at 5:32 PM

$GERN News

Charting the latest market whipsaw 10:59 a.m. Today - Michael Ashbaugh
Oracle active, Geron shares fall after hours 6:06 p.m. Dec. 3, 2012 - Carla Mozee
Geron to discontinue brain-cancer drug development 4:38 p.m. Dec. 3, 2012 - MarketWatch.com
BioTime offers equity stake for Geron assets 8:47 a.m. Oct. 18, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 1:42 p.m. Sept. 10, 2012 - MarketWatch
Geron ends breast cancer study of Imetelstat 7:06 a.m. Sept. 10, 2012 - MarketWatch.com
Stocks to Watch Friday: Splunk, Zumiez, Pandora 3:59 p.m. Aug. 30, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 3:31 p.m. Aug. 30, 2012 - MarketWatch
Geron climbs 11% on analyst rating 9:56 a.m. Aug. 30, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:37 p.m. Nov. 15, 2011 - Kate Gibson
Financial uncertainty nixed Geron stem cell work 2:09 p.m. Nov. 15, 2011 - MarketWatch.com
Stocks to watch Friday: Global Crossing, Clarcor 5:42 a.m. Sept. 30, 2011 - MarketWatch
Court upholds stem-cell research funding: reports 10:46 a.m. July 27, 2011 - Val Brickates Kennedy
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Amylin and Alkermes shine in drug-stocks trading 2:08 p.m. July 8, 2011 - Val Brickates Kennedy
Stem-cell stocks rise on artificial-trachea report 1:57 p.m. July 8, 2011 - Val Brickates Kennedy
Regeneron, Cephalon boost biotech stocks 2:29 p.m. May 2, 2011 - Val Brickates Kennedy
Stem cell researchers gain on U.S. court decision 9:14 a.m. May 2, 2011 - Val Brickates Kennedy
StemCells shares climb on spinal injury study 2:49 p.m. March 14, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 3:09 p.m. Dec. 7, 2010 - Kate Gibson

Interesting GERN Call Options For January 2016 12:44 p.m. Today - TheStreet.com
Geron: Hold Or Take Profits Now? 10:17 a.m. Today - Seeking Alpha
Geron Q3 Loss in Line; Shares Up on ASH Abstract - Analyst Blog 10:00 a.m. Today - Zacks.com
Geron: A Changed Company With Significant Potential 9:59 a.m. Today - Seeking Alpha
Multiple Reasons To Buy Incyte 3:25 p.m. Nov. 8, 2013 - Seeking Alpha
The 10 Dumbest Things This Friday 12:14 p.m. Nov. 8, 2013 - 247WallSt.com
Geron's Promising News Poses No Threat To Incyte 11:53 a.m. Nov. 8, 2013 - Seeking Alpha
Interesting GERN Put And Call Options For January 2015 11:08 a.m. Nov. 8, 2013 - TheStreet.com
Geron Corporation (GERN) Is Today's Perilous Reversal Stock 9:46 a.m. Nov. 8, 2013 - TheStreet.com
Key Issues Surrounding The Zalicus Catalyst Trade 8:56 a.m. Nov. 8, 2013 - Seeking Alpha
Quick Take On Geron's Imetelstat Abstract 9:17 p.m. Nov. 7, 2013 - Seeking Alpha
Geron Management Discusses Q3 2013 Results - Earnings Call Transcript 7:10 p.m. Nov. 7, 2013 - Seeking Alpha
Geron Corporation Discusses Q3 2013 Results (Webcast) 4:25 p.m. Nov. 7, 2013 - Seeking Alpha
Geron Move Seems Hard To Interpret As Sustainable 3:08 p.m. Nov. 7, 2013 - 247WallSt.com
Geron Revealed Positive Imetelstat Results Amidst Data Concerns 12:10 p.m. Nov. 7, 2013 - benzinga.com
Facebook Tests Star-Rating System for Users and 2 Other Hot Stocks to Watch 11:41 a.m. Nov. 7, 2013 - Wall St. Cheat Sheet
Geron's Imetelstat Data in Myelofibrosis: 4 CRs, 1 PR. But Are These Responses Real? (Update) 10:04 a.m. Nov. 7, 2013 - TheStreet.com
Today's Dead Cat Bounce Stock Is Geron Corporation (GERN) 9:45 a.m. Nov. 7, 2013 - TheStreet.com
Geron: Super Important Imetelstat Data Coming Thursday 7:08 a.m. Nov. 5, 2013 - TheStreet.com
First Week Of June 2014 Options Trading For Geron (GERN) 11:28 a.m. Oct. 23, 2013 - TheStreet.com

Earning Forecast Tips for Hot Stocks: Facebook, Tesla, J.C. Penney, Groupon, Geron, and Alcoa 9:00 a.m. Nov. 8, 2013 - PR Newswire
TrendingWallStreet.com Initiates Volume Analysis on TWTR, FNMA, SEEK, and GERN 12:19 a.m. Nov. 8, 2013 - ACCESSWIRE
Geron Corporation Reports Third Quarter 2013 Financial Results 4:11 p.m. Nov. 7, 2013 - Thomson Reuters ONE
WIN, VNDA, BIOS, GERN added to NASDAQ Active Stock Watch List at GSR 10:28 a.m. Nov. 7, 2013 - ACCESSWIRE
Geron Announces Conference Call to Discuss Third Quarter 2013 Financial Results 3:01 p.m. Nov. 1, 2013 - Thomson Reuters ONE
Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc. 8:00 a.m. Oct. 31, 2013 - PR Newswire
Divestiture, Clinical Study Updates, New Drug Application, and Quarterly Report - Research Report on Geron, NPS, Portola, MannKind, and Exact Sciences 7:00 a.m. Oct. 21, 2013 - PR Newswire
Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp. 8:26 a.m. Oct. 8, 2013 - PR Newswire
TSLA, AGNC, GERN and ZLCS added to Nasdaq Active Stock Watch List at GSR 8:05 a.m. Oct. 1, 2013 - ACCESSWIRE
Geron Completes Divestiture of Stem Cell Assets 8:01 a.m. Oct. 1, 2013 - Thomson Reuters ONE
Asterias Biotherapeutics, Inc., a Subsidiary of BioTime, Inc., Acquires Geron's Embryonic Stem Cell Assets 8:00 a.m. Oct. 1, 2013 - BusinessWire
FSLR, LINE, GERN and CLDX added to NASDAQ Active Stock Watch List at EPR 8:05 a.m. Sept. 24, 2013 - ACCESSWIRE
Edge Therapeutics Elects Robert J. Spiegel, MD To Board of Directors 5:30 a.m. Sept. 10, 2013 - BusinessWire
Geron to Present at the Stifel Healthcare Conference 3:00 p.m. Sept. 4, 2013 - Thomson Reuters ONE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, GERN, NKTR and NPSP 8:01 a.m. Aug. 12, 2013 - ACCESSWIRE
Geron Corporation Reports Second Quarter 2013 Financial Results 3:06 p.m. Aug. 8, 2013 - Thomson Reuters ONE
Geron Announces Conference Call to Discuss Second Quarter 2013 Financial Results 3:31 p.m. July 29, 2013 - Thomson Reuters ONE
Arena Pharma, Geron, Incyte, and Spectrum Pharma Under AAAResearchReports.com Microscope 9:56 a.m. July 29, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GERN, IMMU and ITMN 7:48 a.m. July 2, 2013 - ACCESSWIRE
Early Morning Insight: Arena Pharmaceuticals, Geron, Celgene, Incyte, and Spectrum Pharmaceuticals 7:59 a.m. June 25, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Miranda Lambert Lights Up Red Kettle Campaign

By Logan Wright Updated Oct 25, 2026 Category News Views 178

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Love Business Group Helps SMEs Navigate Broadband Choices

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Firefox Champions Privacy with Iconic Internet Campaign

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

D-Wave Investors Must Decide by Dec 15 Class Suit

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Air Sealing First: Boosting Home Comfort & Efficiency

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...